Inventor
RUKHMAN IGOR
IL20 patents
⚠️ This page may combine multiple inventors who share the name “RUKHMAN IGOR”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
TEVA PHARMA
11 patentsUS7332612B2Feb 19, 2008
Amorphous and crystalline forms of losartan potassium and process for their preparation
TEVA PHARMA8 citations73
US7227026B2Jun 5, 2007
Synthesis of irbesartan
TEVA PHARMA3 citations73
US7217825B2May 15, 2007
Synthesis of irbesartan
TEVA PHARMA3 citations73
US7038060B2May 2, 2006
Synthesis of 2-butyl-3-(2′-(1-trityl-1H-tetrazol-5-yl)biphenyl-4-yl)-1,3-diazaspiro[4.4]-non-ene-4-one
TEVA PHARMA8 citations73
US7019148B2Mar 28, 2006
Synthesis of irbesartan
TEVA PHARMA7 citations73
US7838683B2Nov 23, 2010
Synthesis of irbesartan
TEVA PHARMA1 citations62
US7378531B2May 27, 2008
Process for the preparation of valsartan
TEVA PHARMA4 citations61
US7105557B2Sep 12, 2006
Polymorphs of valsartan
TEVA PHARMA3 citations60
US7199144B2Apr 3, 2007
Process for the preparation of valsartan and intermediates thereof
TEVA PHARMA5 citations59
US7312340B2Dec 25, 2007
Synthesis of 2-butyl-3-(1-trityl-1H-tetrazol-5-YL)biphenyl-4-YL)-1,3-diazaspiro[4,4]- non-ene-4-one
TEVA PHARMA0 citations51
US7301035B2Nov 27, 2007
Intermediates for the synthesis of irbesartan
TEVA PHARMA0 citations51
SVC PHARMA LP
3 patentsUS9744151B2Aug 29, 2017
Methods for purifying trans-(−)-Δ9-tetrahydrocannabinol and trans-(+)-Δ9-tetrahydrocannabinol
SVC PHARMA LP6 citations81
US9278083B2Mar 8, 2016
Methods for purifying trans-(−)-Δ9-tetrahydrocannabinol and trans-(+)-Δ9-tetrahydrocannabinol
SVC PHARMA LP4 citations81
US9675581B2Jun 13, 2017
Methods for purifying trans-(−)-Δ9-tetrahydrocannabinol and trans- (+)-Δ9-tetrahydrocannabinol
SVC PHARMA LP0 citations49